← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $314K of Karuna Therapeutics, Inc.

Sold$313,575
$125.43Price
2,500Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Mon, Mar 1. Filed Wed, Mar 3, 4:19 PM ET, after the close. Not investment advice.